Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Summary

The purpose of this study is to determine the efficacy of intravitreal aflibercept injections administered in a treat and extend fashion in eyes that have persistent center involved diabetic macular edema following at least 4 intravitreal injections of 0.3 mg ranibizumab over 24 weeks.

Timeline

Start

2018-06-01

Primary completion

2020-06-30

Completion

2020-09-30

Drugs

Indications